← Back to Search

Buzzy for Chronic Pain

N/A

Waitlist Available

Led By Frederic Gerges, MD

Research Sponsored by Steward St. Elizabeth's Medical Center of Boston, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients receiving lidocaine infusions at the pain clinic.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 2 months

Awards & highlights

Study Summary

This trial is testing a device to reduce IV pain during lidocaine infusions for adults with chronic pain.

Eligible Conditions

Chronic Pain
Acute Pain

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 2 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 2 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pain

Secondary outcome measures

Satisfaction on the Visual Analog Scale

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: BuzzyExperimental Treatment1 Intervention

Buzzy will be applied 5 to 10 cm proximal (toward the subject's head) to the dorsum of the hand site immediately prior and throughout the intravenous catheter insertion attempt.

Group II: No BuzzyActive Control1 Intervention

Subjects will have a 20g intravenous catheter inserted either in the left or right dorsum side of the hand without the Buzzy device.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Buzzy

2018

Completed Phase 2

~1240

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Steward St. Elizabeth's Medical Center of Boston, Inc.Lead Sponsor

25 Previous Clinical Trials

5,741 Total Patients Enrolled

Frederic Gerges, MDPrincipal InvestigatorPain Medicine Physician

Media Library

Buzzy Clinical Trial Eligibility Overview. Trial Name: NCT05555173 — N/A

Chronic Pain Research Study Groups: Buzzy, No Buzzy

Chronic Pain Clinical Trial 2023: Buzzy Highlights & Side Effects. Trial Name: NCT05555173 — N/A

Buzzy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05555173 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study enlisting new participants at present?

"Indeed, research posted on clinicaltrials.gov points to an active recruitment period that began October 1st 2022 and was most recently updated December 14th 2022. This study is seeking 100 participants from a single site."

Answered by AI

What is the overall admission capacity for this clinical research?

"Yes, the information posted on clinicaltrials.gov implies that this trial is presently seeking participants. The original posting date was October 1st 2022 and it has recently been updated on December 14th of the same year. To complete recruitment, a total of 100 subjects need to be enrolled at one location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

IVs With Buzzy in Chronic Pain Patients

2022. "IVs With Buzzy in Chronic Pain Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05555173.